Reassessing Novavax (NVAX) After Recent Share Price Rebound And Valuation Signals

If you are wondering whether Novavax (Nasdaq: NVAX) is priced attractively or already reflects its story, you are not alone. The stock last closed at US$9.75, with returns of 21.7% over 7 days, 40.5% ...
Medical Marketing & Media

Rx Rundown: Bristol Myers Squibb, Corxel Pharmaceuticals, GSK and more

GSK is set to buy Rapt Therapeutics in a $2.2 billion deal. AstraZeneca agreed to a $630 million pact to secure remaining rights to armored CAR-T from AbelZeta. Bristol Myers Squibb signed a deal with ...

Bank of America Securities Sticks to Their Sell Rating for Erasca (ERAS)

Bank of America Securities analyst Alec Stranahan maintained a Sell rating on Erasca today and set a price target of $2.00.
The Canadian Press on MSN

Today-History-Feb01

--- ...

Adar Poonawala

Get all latest & breaking news on Adar Poonawala. Watch videos, top stories and articles on Adar Poonawala at moneycontrol.com.